Field Trip Health Archives

Psychedelics News

Field Trip Health

Industry

29 Apr 2022

Field Trip to Split Into Two Independent Public Companies

Big news as Field Trip Health splits its operations into two separate publicly-traded companies....

By Microdose

Industry

5 Apr 2022

Field Trip Granted Patent for Lead Compound FT-104

Today they continued to deliver on their projected milestones with the announcement that the patent has been formally granted and gives exclusive rights to Field Trip....

By Jason Najum

Finance

23 Feb 2022

A Look at Recent Financial and Business Highlights

To help keep you updated, we’ve put together a summary of recent financial announcements from a variety of psychedelic medicine companies....

By Jason Najum

Industry

12 Jan 2022

Field Trip’s FT-104 Clears Patent Approval Process

The Allowance is final major step in the patent process, with actual granting of the patent normally coming soon after....

By Jason Najum

Join Our Newsletter for Exclusive Updates, Stories, and More

Don’t Miss

25 Oct 2021

News You Might Have Missed: Oct 25, 2021

Welcome to the News You Might Have Missed, a weekly roundup of psychedelic medicine industry news items to help you catch up and stay informed....

By Jason Najum

Press Releases

17 Mar 2021

Field Trip Health Ltd. Announces Closing of $95 Million Bought Deal Financing

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, March 17, 2021 (GLOBE NEWSWIRE) — Field Trip Health Ltd....

By Microdose

Press Releases

26 Feb 2021

Field Trip Health Announces Upsize to Previously Announced Bought Deal Public Offering

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES....

By Microdose

Press Releases

25 Feb 2021

Field Trip Health Announces $50 Million Bought Deal Offering of Common Shares

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES....

By Microdose

Press Releases

16 Feb 2021

Field Trip Health Ltd. Reports Third Fiscal Quarter 2021 Financial Results

Q3 2021 patient services revenues of $316,329 represent a 235% increase over the previous quarter Field Trip continues to advance development of FT-104, a novel psychedelic molecule with pending patents...

By Microdose

Follow us on social

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result